Biohacked : China's Race to Control Life

個数:

Biohacked : China's Race to Control Life

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 264 p.
  • 言語 ENG
  • 商品コード 9781641773225
  • DDC分類 338.4766060951

Full Description

When COVID-19 erupted from Wuhan, China under mysterious circumstances, the Communist Party of China covered up its existence for as long as possible. It is now apparent that there is more to COVID than what the authorities wish for us to know. Biohacked: China's Race to Control Life details the decades-long pursuit by the Chinese Communists to dominate the biotechnology industry—to control the very building blocks of life on Earth—to further their political control at home and their supremacy abroad. 

More appalling than the egregious cover-up that China's rulers engaged in with COVID-19 is the fact that Western scientists, pharmaceutical companies, and research labs have contributed to China's rapid (and dangerous) growth in the biotech industry—so much so that China, not the United States, may become the seat of the biotechnology industry. The Chinese leadership believes that biotechnology is a critical industry for the Communist Party to achieve its goal of becoming the world's dominant superpower by 2049. In China's biotech sector, truly macabre practices are being developed, from ambitious cloning programs to the creation of potential pathogens that China's military plans to use in "specific genetic attacks" against Beijing's growing list of political enemies.

To stop the threat, author Brandon J. Weichert proposes the world's nations create a comprehensive set of treaties for regulating biotechnology research and development. Further, Weichert calls for Washington to slow the transfer of advanced biotechnology knowledge and funding from the United States to China using means like the Foreign Corrupt Practices Act and the Committee on Foreign Investment in the United States (CFIUS). 

Unless an all-of-government (and society) approach is taken to curbing irresponsible biotech development in China, then another—deadlier—COVID-19-like pandemic could be at hand.

最近チェックした商品